Catheter Precision, Inc. (VTAK)
NYSEAMERICAN: VTAK · Real-Time Price · USD
0.933
+0.033 (3.64%)
At close: Apr 28, 2026, 4:00 PM EDT
0.933
0.00 (0.00%)
Pre-market: Apr 29, 2026, 6:30 AM EDT
Catheter Precision Revenue
In the year 2025, Catheter Precision had annual revenue of $819.00K with 95.00% growth. Catheter Precision had revenue of $238.00K in the quarter ending December 31, 2025, with 59.73% growth.
Revenue (ttm)
$819.00K
Revenue Growth
+95.00%
P/S Ratio
3.07
Revenue / Employee
$37,227
Employees
22
Market Cap
2.51M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WORK Medical Technology Group LTD | 9.85M |
| Nuwellis | 8.27M |
| INVO Fertility | 6.94M |
| Beyond Air | 6.92M |
| Intelligent Bio Solutions | 3.58M |
| ENvue Medical | 2.55M |
| Tivic Health Systems | 482.00K |
| Profusa | 75.00K |
VTAK News
- 1 day ago - Flyte Deploys Additional Vision Jets in the Northeast to Capture Surging Summer Demand - GlobeNewsWire
- 8 days ago - FLYTE EMERGES AS DIRECT BENEFICIARY AS RISING FUEL COSTS DRIVE AIRLINE RETREAT FROM SHORT-HAUL ROUTES - GlobeNewsWire
- 23 days ago - New LockeT Data Accepted in Leading Electrophysiology Journal - GlobeNewsWire
- 4 weeks ago - Catheter Precision Reports 2025 Results and Updates on Strategic Expansion - GlobeNewsWire
- 7 weeks ago - VTAK Announces Definitive Merger Agreement to Acquire 100% of Fly Flyte Inc. - GlobeNewsWire
- 7 weeks ago - Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026 - GlobeNewsWire
- 2 months ago - Catheter Precision Divests Non-Core Assets As It Shifts Focus - Benzinga
- 2 months ago - Catheter Precision Announces Strategic Sale of Non-Core Assets to Strengthen Balance Sheet and Accelerate Electrophysiology Growth - GlobeNewsWire